Coloplast A/S (LON: 0QBO)

Market Cap	20.93B
Revenue (ttm)	3.02B
Net Income (ttm)	563.75M
Shares Out	n/a
EPS (ttm)	2.51
PE Ratio	37.13
Forward PE	n/a
Dividend	2.47 (0.30%)
Ex-Dividend Date	Dec 6, 2024

Volume	12,002
Average Volume	19,599
Open	832.90
Previous Close	814.68
Day's Range	819.00 - 836.20
52-Week Range	84.20 - 108.53
Beta	0.34
RSI	56.58
Earnings Date	Feb 4, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 16,639
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QBO

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK